Solventum

SOLV · NYSE · USD

$87.85Change from previous close: +0.09%Absolute change: +$0.08

Close · October 2, 2026

At a glance

Revenue growth
+0.86%
2025 vs 2024
Net income growth
+224.84%
2025 vs 2024
Net margin
18.7%
2024: 5.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total assets14,24314,09714,29413,97315,074—
Current assets3,7413,5833,8594,4073,208—
Cash and equivalents4035618781,642492—
Receivables1,4321,1801,1841,1761,255—
Inventory1,0401,0891,0661,049962—
Net property, plant and equipment1,7531,7291,3261,3361,313—
Goodwill5,6265,6265,7045,2605,274—
Other intangible assets2,4082,4982,5922,2232,302—
Current liabilities3,6633,3463,1362,9382,620—
Accounts payable701699687669643—
Long-term debt4,5734,5755,0355,1377,815—
Total debt5,2865,2875,0355,1377,815—
Total liabilities9,4449,1279,2448,98711,429—
Total equity (incl. minority)4,7994,9705,0504,9863,645—
Retained earnings1,9021,8101,7971,734468—